SIG
IBB icon

Sargent Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

Sargent Investment Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245K Hold
1,449
– – 0.03% 228
2025
Q4 		$245K Buy
+1,449
New +$235K 0.03% 226
2024
Q4 		– Sell
-1,449
Closed -$211K – 245
2024
Q3 		$211K Buy
+1,449
New +$210K 0.04% 203
2024
Q1 		– Sell
-1,999
Closed -$272K – 212
2023
Q4 		$272K Sell
1,999
-158
-7% -$19.3K 0.06% 176
2023
Q3 		$264K Hold
2,157
– – 0.06% 164
2023
Q2 		$274K Hold
2,157
– – 0.07% 163
2023
Q1 		$280K Hold
2,157
– – 0.07% 157
2022
Q4 		$283K Sell
2,157
-100
-4% -$12.9K 0.09% 145
2022
Q3 		$276K Hold
2,257
– – 0.09% 141
2022
Q2 		$265K Hold
2,257
– – 0.08% 149
2022
Q1 		$294K Buy
2,257
+105
+5% +$13.7K 0.07% 152
2021
Q4 		$328K Sell
2,152
-25
-1% -$3.87K 0.07% 143
2021
Q3 		$352K Buy
2,177
+120
+6% +$20.2K 0.09% 138
2021
Q2 		$337K Hold
2,057
– – 0.08% 150
2021
Q1 		$310K Buy
2,057
+404
+24% +$64.2K 0.08% 150
2020
Q4 		$250K Sell
1,653
-50
-3% -$7.15K 0.08% 151
2020
Q3 		$231K Hold
1,703
– – 0.08% 144
2020
Q2 		$234K Buy
+1,703
New +$217K 0.09% 133
2019
Q3 		– Sell
-2,093
Closed -$228K – 149
2019
Q2 		$228K Buy
2,093
+138
+7% +$14.7K 0.1% 125
2019
Q1 		$219K Buy
+1,955
New +$214K 0.11% 124

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sargent Investment Group's IBB Position: Q1 2026 in Review

Sargent Investment Group held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,449 shares worth $245K. The position accounts for 0.03% of the portfolio, ranked #228.

Sargent Investment Group first reported a position in IBB in Q1 2019 and has held it in 20 quarters since. The position peaked at $352K in Q3 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Sargent Investment Group held 1,449 shares of iShares Biotechnology ETF worth $245K as of Q1 2026.
  • Sargent Investment Group left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.03% of Sargent Investment Group's portfolio in Q1 2026, its #228 holding.
  • Sargent Investment Group first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 20 quarters since.
  • Sargent Investment Group's iShares Biotechnology ETF position peaked at $352K in Q3 2021.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.